Listen: Europe’s vaccine safety scare, Lilly’s Alzheimer’s data, & a plea for transparency

Has Europe lost the plot with Covid-19 vaccines? Can the latest treatment for Alzheimer’s disease succeed where so many others failed? And why don’t biotech companies just come clean when things go wrong?

We discuss all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First we unpack the crisis of confidence facing AstraZeneca’s Covid-19 vaccine in Europe with Alison Buttenheim, a University Pennsylvania professor who studies vaccine acceptance. Then, we explain the latest data on an Alzheimer’s disease treatment from Eli Lilly and why it has polarized experts in the field. Finally, we make a modest proposal to the biotech industry: Give honesty a chance.

For more on what we cover, here’s an update on AstraZeneca; here’s the latest on Lilly’s Alzheimer’s drug; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the coronavirus pandemic.

advertisement

Be sure to sign up on Apple PodcastsStitcherGoogle Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

advertisement


Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].

Source: STAT